171 related articles for article (PubMed ID: 35390598)
1. Polymeric nanoparticles for the delivery of Sonoran desert propolis: Synthesis, characterization and antiproliferative activity on cancer cells.
Mendez-Pfeiffer P; Juarez J; Hernandez J; Taboada P; Virués C; Alday E; Valencia D; Velazquez C
Colloids Surf B Biointerfaces; 2022 Jul; 215():112475. PubMed ID: 35390598
[TBL] [Abstract][Full Text] [Related]
2. Plant origin authentication of Sonoran Desert propolis: an antiproliferative propolis from a semi-arid region.
Alday E; Valencia D; Garibay-Escobar A; Domínguez-Esquivel Z; Piccinelli AL; Rastrelli L; Monribot-Villanueva J; Guerrero-Analco JA; Robles-Zepeda RE; Hernandez J; Velazquez C
Naturwissenschaften; 2019 May; 106(5-6):25. PubMed ID: 31069518
[TBL] [Abstract][Full Text] [Related]
3. Seasonality Modulates the Cellular Antioxidant Activity and Antiproliferative Effect of Sonoran Desert Propolis.
Mendez-Pfeiffer P; Alday E; Carreño AL; Hernández-Tánori J; Montaño-Leyva B; Ortega-García J; Valdez J; Garibay-Escobar A; Hernandez J; Valencia D; Velazquez C
Antioxidants (Basel); 2020 Dec; 9(12):. PubMed ID: 33348680
[TBL] [Abstract][Full Text] [Related]
4. Biosynthesis of Silver Nanoparticles Using Seasonal Samples of Sonoran Desert Propolis: Evaluation of Its Antibacterial Activity against Clinical Isolates of Multi-Drug Resistant Bacteria.
Mendez-Pfeiffer P; Ballesteros-Monrreal MG; Gaona-Ochoa J; Juarez J; Gastelum-Cabrera M; Montaño-Leyva B; Arenas-Hernández M; Caporal-Hernandez L; Ortega-García J; Barrios-Villa E; Velazquez C; Valencia D
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145600
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic induction by pinobanksin and some of its ester derivatives from Sonoran propolis in a B-cell lymphoma cell line.
Alday E; Valencia D; Carreño AL; Picerno P; Piccinelli AL; Rastrelli L; Robles-Zepeda R; Hernandez J; Velazquez C
Chem Biol Interact; 2015 Dec; 242():35-44. PubMed ID: 26367700
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
8. Ergosterol-loaded poly(lactide-co-glycolide) nanoparticles with enhanced in vitro antitumor activity and oral bioavailability.
Zhang HY; Firempong CK; Wang YW; Xu WQ; Wang MM; Cao X; Zhu Y; Tong SS; Yu JN; Xu XM
Acta Pharmacol Sin; 2016 Jun; 37(6):834-44. PubMed ID: 27133301
[TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.
Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS
Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
[TBL] [Abstract][Full Text] [Related]
12. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A
Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665
[TBL] [Abstract][Full Text] [Related]
13. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages.
Guedj AS; Kell AJ; Barnes M; Stals S; Gonçalves D; Girard D; Lavigne C
Int J Nanomedicine; 2015; 10():5965-79. PubMed ID: 26445538
[TBL] [Abstract][Full Text] [Related]
15. Development of 6-Thioguanine conjugated PLGA nanoparticles through thioester bond formation: Benefits of electrospray mediated drug encapsulation and sustained release in cancer therapeutic applications.
Chatterjee M; Jaiswal N; Hens A; Mahata N; Chanda N
Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111029. PubMed ID: 32994006
[TBL] [Abstract][Full Text] [Related]
16. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.
Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U
Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238
[TBL] [Abstract][Full Text] [Related]
17. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
19. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
20. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin.
Khaledi S; Jafari S; Hamidi S; Molavi O; Davaran S
J Biomater Sci Polym Ed; 2020 Jun; 31(9):1107-1126. PubMed ID: 32249693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
